Zhang, G., Liu, Y., Shen, D., Chen, Y., He, Y., Wang, H., Wang, L., Zhang, H., Zhang, H., Zhao, J., Sang, Y., Wang, M., Liu, H., Liu, J., Yan, X., Song, P. (2025). Neoadjuvant and adjuvant iruplinalkib in resectable
            <i>ALK</i>
            or
            <i>ROS1</i>
            fusion-positive, non-small cell lung cancer (NSCLC): The preliminary results of the single-arm, exploratory Neo-INFINITY study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e20044